TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing Oct 17, 2018 11:45AM
Tapimmune, Inc. (TPIV) Prices 17.5M Share Private Placement at $4/Share, to Issue 13.13M Warrants Jun 8, 2018 09:18AM
TapImmune Announces Pricing of $70 Million Private Placement Jun 8, 2018 09:15AM
TapImmune and Marker Therapeutics Announce Entry into Merger Agreement, Creating a Transformational Immuno-Oncology Platform May 15, 2018 05:32AM